Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients

INTRODUCTION: The measurement of body composition such as the skeletal muscle index (SMI) has been reported to be useful for predicting prognosis in hepatocellular carcinoma (HCC). In this study, we analyzed skeletal muscle change during sorafenib and lenvatinib therapy and the association between S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Cancer
Main Authors: Uchikawa, Shinsuke, Kawaoka, Tomokazu, Namba, Maiko, Kodama, Kenichiro, Ohya, Kazuki, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Takahashi, Shoichi, Chayama, Kazuaki, Aikata, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206610/
https://ncbi.nlm.nih.gov/pubmed/32399429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503829
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados